homocysteine has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abletshauser, C; Goedicke, C; Haak, E; Haak, T; Hermanns, N; Kusterer, K; Lackner, K; Martin, N; Usadel, KH; Weber, S | 1 |
| Brzósko, S; Małyszko, J; Małyszko, JS; Myśliwiec, M; Pawlak, K | 1 |
| Holubec, L; Mayer, O; Pikner, R; Simon, J; Subrt, I | 1 |
| Holubec, L; Mayer, O; Pikner, R; Simon, J; Trefil, L | 1 |
| Abletshauser, C; Freisinger, F; März, W; Scharnagl, H; Stojakovic, T; Vogel, M | 1 |
4 trial(s) available for homocysteine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
| Article | Year |
|---|---|
Fluvastatin therapy improves microcirculation in patients with hyperlipidaemia.
Topics: Anticholesteremic Agents; Arteriosclerosis; Blood Proteins; Capillaries; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Fatty Acids, Monounsaturated; Fluvastatin; Hemostasis; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperemia; Hyperlipidemias; Indoles; Laser-Doppler Flowmetry; Microcirculation; Microscopy, Video; Risk Factors; Time Factors; Triglycerides | 2001 |
Fenofibrate-induced hyperhomocysteinemia may be prevented by folate co-administration.
Topics: Aged; Anticholesteremic Agents; Cross-Over Studies; Fatty Acids, Monounsaturated; Female; Fenofibrate; Fluvastatin; Folic Acid; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; Hypolipidemic Agents; Indoles; Male; Middle Aged; Prospective Studies | 2003 |
Folate co-administration improves the effectiveness of fenofibrate to decrease the lipoprotein oxidation and endothelial dysfunction surrogates.
Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Drug Therapy, Combination; Endothelium, Vascular; Fatty Acids, Monounsaturated; Female; Fenofibrate; Fluvastatin; Folic Acid; Homocysteine; Humans; Hypercholesterolemia; Hypolipidemic Agents; Indoles; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Prospective Studies; Thrombomodulin; Treatment Outcome; Triglycerides; Vitamin B Complex; von Willebrand Factor | 2006 |
Efficacy and safety of fluvastatin-extended release in hypercholesterolemic patients: morning administration is equivalent to evening administration.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Apolipoproteins B; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Circadian Rhythm; Delayed-Action Preparations; Fatty Acids, Monounsaturated; Female; Fluvastatin; Homocysteine; Humans; Hypercholesterolemia; Indoles; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2006 |
1 other study(ies) available for homocysteine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
| Article | Year |
|---|---|
Effects of fluvastatin on homocysteine and serum lipids in kidney allograft recipients.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Female; Fibrinogen; Fluvastatin; Homocysteine; Humans; Indoles; Kidney Transplantation; Lipids; Lipoprotein(a); Male; Middle Aged; Osmolar Concentration; Time Factors; Transplantation, Homologous; Triglycerides | 2002 |